Results 241 to 250 of about 6,653 (267)

Mild Hyperthermia-Enhanced Enzyme-Mediated Tumor Cell Chemodynamic Therapy

ACS Applied Materials & Interfaces, 2019
The heterogeneity and diversity of tumors seriously attenuate the curative outcome of single treatment modes. Combined therapy has been demonstrated to be a promising candidate to enhance therapeutic efficacy compared with monotherapy. As an emerging therapeutic strategy, chemodynamic therapy (CDT) has drawn extensive attention in recent years. However,
Xinhe Liu, Ying Liu, Junning Wang, Tianxiang Wei, Zhihui Dai   +4 more
openaire   +2 more sources

Biodegradable CoS2 nanoclusters for photothermal-enhanced chemodynamic therapy

Applied Materials Today, 2020
Abstract Retaining in tumors for cancer diagnosis/treatment with sequential elimination from body is crucial to the clinical translation of inorganic medicaments. Herein, monodispersed CoS2 nanoclusters (CoS2 NCs) assembled from ultrasmall nanocrystals oligomerization via the La Mer scheme were successfully developed for chemodynamic therapy (CDT) of
Xianwen Wang, Xiaoyan Zhong, Zhengbao Zha, Gang He, Zhaohua Miao, Huali Lei, Qunyi Luo, Rui Zhang, Zhuang Liu, Liang Cheng   +9 more
openaire   +1 more source

Multimodal tumor therapy based on chemodynamic therapy

Chinese Journal of Analytical Chemistry, 2022
Xiao ZHU-GE, Dong-Mei XI, Shu-Sheng ZHANG   +2 more
openaire   +1 more source

Biodegradable hollow mesoporous bimetallic nanoreactors to boost chemodynamic therapy

Journal of Colloid and Interface Science
As an endogenous catalytic treatment, chemodynamic therapy (CDT) was attracting considerable attention, but the weak catalytic efficiency of Fenton agents and the non-degradation of nanocarriers severely limited its development. In this work, a biodegradable bimetallic nanoreactor was developed for boosting CDT, in which Fe-doped hollow mesoporous ...
Yu, Shi, Linna, Chang, Chunshu, Pan, Hao, Zhang, Yiqian, Yang, Aiguo, Wu, Leyong, Zeng   +6 more
openaire   +2 more sources

Janus ACSP Nanoparticle for Synergistic Chemodynamic Therapy and Radiosensitization

ACS Applied Materials & Interfaces
Protective autophagy and DNA damage repair lead to tumor radio-resistance. Some hypoxic tumors exhibit a low radiation energy absorption coefficient in radiation therapy. High doses of X-rays may lead to side effects in the surrounding normal tissues.
Mingzhen Xu, Yuyi Qian, Xinyi Li, Bingxin Gu, Simin He, Xin Lu, Shaoli Song   +6 more
openaire   +2 more sources

Radiation therapy‐associated toxicity: Etiology, management, and prevention

Ca-A Cancer Journal for Clinicians, 2021
Kyle Wang
exaly  

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

Ca-A Cancer Journal for Clinicians, 2022
William A Hal, X Allen Li, Daniel A Low
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly